Gene, Cell and Tissue

Published by: Kowsar

Novel Insight Into Intellectual Disability; A Review Article

Negin Parsamanesh 1 and Ebrahim Miri-Moghaddam 2 , *
Authors Information
1 Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Molecular Medicine, Cardiovascular Diseases Research Center, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Gene, Cell and Tissue: 5 (4); e84401
  • Published Online: December 26, 2018
  • Article Type: Review Article
  • Received: September 18, 2018
  • Revised: December 16, 2018
  • Accepted: December 18, 2018
  • DOI: 10.5812/gct.84401

To Cite: Parsamanesh N, Miri-Moghaddam E. Novel Insight Into Intellectual Disability; A Review Article, Gene Cell Tissue. Online ahead of Print ; 5(4):e84401. doi: 10.5812/gct.84401.

Copyright © 2018, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Definitions
2. Intellectual Disability Classification
3. Etiology
4. ID Diagnosis
5. Main Synaptic Signaling Pathways Effective in Intellectual Disability
6. Conclusions
  • 1. Kriek M, Knijnenburg J, White SJ, Rosenberg C, den Dunnen JT, van Ommen GJ, et al. Diagnosis of genetic abnormalities in developmentally delayed patients: A new strategy combining MLPA and array-CGH. Am J Med Genet A. 2007;143A(6):610-4. doi: 10.1002/ajmg.a.31593. [PubMed: 17318845].
  • 2. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478(7367):57-63. doi: 10.1038/nature10423. [PubMed: 21937992].
  • 3. Rafati M, Seyyedaboutorabi E, Ghadirzadeh MR, Heshmati Y, Adibi H, Keihanidoust Z, et al. "Familial" versus "Sporadic" intellectual disability: Contribution of common microdeletion and microduplication syndromes. Mol Cytogenet. 2012;5(1):9. doi: 10.1186/1755-8166-5-9. [PubMed: 22283845]. [PubMed Central: PMC3284449].
  • 4. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367(20):1921-9. doi: 10.1056/NEJMoa1206524. [PubMed: 23033978].
  • 5. Ansar M, Riazuddin S, Sarwar MT, Makrythanasis P, Paracha SA, Iqbal Z, et al. Biallelic variants in LINGO1 are associated with autosomal recessive intellectual disability, microcephaly, speech and motor delay. Genet Med. 2018;20(7):778-84. doi: 10.1038/gim.2017.113. [PubMed: 28837161].
  • 6. Abbasi-Moheb L, Mertel S, Gonsior M, Nouri-Vahid L, Kahrizi K, Cirak S, et al. Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am J Hum Genet. 2012;90(5):847-55. doi: 10.1016/j.ajhg.2012.03.021. [PubMed: 22541559]. [PubMed Central: PMC3376487].
  • 7. Hu H, Kahrizi K, Musante L, Fattahi Z, Herwig R, Hosseini M, et al. Genetics of intellectual disability in consanguineous families. Mol Psychiatry. 2018. doi: 10.1038/s41380-017-0012-2. [PubMed: 29302074].
  • 8. Miri-Moghaddam E, Zadeh-Vakili A, Nikravesh A, Sistani SS, Naroie-Nejad M. Sistani population: A different spectrum of beta-thalassemia mutations from other ethnic groups of Iran. Hemoglobin. 2013;37(2):138-47. doi: 10.3109/03630269.2013.769886. [PubMed: 23437895].
  • 9. Miri-Moghaddam E, Nikravesh A, Gasemzadeh N, Badaksh M, Rakhshi N. Spectrum of alpha-globin gene mutations among premarital Baluch couples in southeastern Iran. Int J Hematol Oncol Stem Cell Res. 2015;9(3):138-42. [PubMed: 26261699]. [PubMed Central: PMC4529681].
  • 10. Miri-Moghaddam E, Bahrami S, Naderi M, Bazi A, Karimipoor M. Molecular characterization of beta-thalassemia intermedia in southeast Iran. Hemoglobin. 2016;40(3):173-8. doi: 10.3109/03630269.2016.1167735. [PubMed: 27117567].
  • 11. Emery AEH. Rimoin DL, editor. Emery and Rimoin's principles and practice of medical genetics. Churchill Livingstone Elsevier; 2007.
  • 12. Leonard H, Wen X. The epidemiology of mental retardation: Challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev. 2002;8(3):117-34. doi: 10.1002/mrdd.10031. [PubMed: 12216056].
  • 13. Aicardi J. The etiology of developmental delay. Semin Pediatr Neurol. 1998;5(1):15-20. [PubMed: 9548636].
  • 14. Rafiq MA, Kuss AW, Puettmann L, Noor A, Ramiah A, Ali G, et al. Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am J Hum Genet. 2011;89(1):176-82. doi: 10.1016/j.ajhg.2011.06.006. [PubMed: 21763484]. [PubMed Central: PMC3135808].
  • 15. National Academies of Sciences, Engineering, and Medicine. Prevalence of intellectual : Boat TF, Wu JT, editors. Mental disorders and disabilities among low-income children. National Academies Press; 2015.
  • 16. Rauch A, Hoyer J, Guth S, Zweier C, Kraus C, Becker C, et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A. 2006;140(19):2063-74. doi: 10.1002/ajmg.a.31416. [PubMed: 16917849].
  • 17. Wakefield J. New centers to focus on autism and other developmental disorders. Environ Health Perspect. 2002;110(1):A20-1. doi: 10.1289/ehp.110-a20. [PubMed: 11781177]. [PubMed Central: PMC1240703].
  • 18. Ropers HH, Hamel BC. X-linked mental retardation. Nat Rev Genet. 2005;6(1):46-57. doi: 10.1038/nrg1501. [PubMed: 15630421].
  • 19. Tsukada K, Imataka G, Suzumura H, Arisaka O. Better prognosis in newborns with trisomy 13 who received intensive treatments: A retrospective study of 16 patients. Cell Biochem Biophys. 2012;63(3):191-8. doi: 10.1007/s12013-012-9355-0. [PubMed: 22487910]. [PubMed Central: PMC3372784].
  • 20. Rosa RF, Rosa RC, Zen PR, Graziadio C, Paskulin GA. Trisomy 18: Review of the clinical, etiologic, prognostic, and ethical aspects. Rev Paul Pediatr. 2013;31(1):111-20. [PubMed: 23703053].
  • 21. Tomac V, Pušeljić S, Škrlec I, Anđelić M, Kos M, Wagner J. Etiology and the genetic basis of intellectual disability in the pediatric population. South Med J. 2017;1(1). doi: 10.26332/seemedj.v1i1.28.
  • 22. Shaffer LG, Ledbetter DH, Lupski JR. Molecular cytogenetics of contiguous gene syndromes: Mechanisms and consequences of gene dosage imbalance. Metab Mol Basis Inherited Dis. 2001;1:1291-324.
  • 23. Nichol K, Pearson CE. CpG methylation modifies the genetic stability of cloned repeat sequences. Genome Res. 2002;12(8):1246-56. doi: 10.1101/gr.74502. [PubMed: 12176932]. [PubMed Central: PMC186631].
  • 24. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, et al. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992;1(6):397-400. [PubMed: 1301913].
  • 25. Walter J, Paulsen M. Imprinting and disease. Semin Cell Dev Biol. 2003;14(1):101-10. [PubMed: 12524013].
  • 26. Jauregi J, Arias C, Vegas O, Alen F, Martinez S, Copet P, et al. A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. J Intellect Disabil Res. 2007;51(Pt 5):350-65. doi: 10.1111/j.1365-2788.2006.00883.x. [PubMed: 17391252].
  • 27. Hamdan FF, Srour M, Capo-Chichi JM, Daoud H, Nassif C, Patry L, et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet. 2014;10(10). e1004772. doi: 10.1371/journal.pgen.1004772. [PubMed: 25356899]. [PubMed Central: PMC4214635].
  • 28. Neimark J. Autism: It's not just in the head. Discover New York. 2007;28(4):32.
  • 29. National Research Council; Division on Earth and Life Studies; Commission on Life Sciences; Board on Environmental Studies and Toxicology; Committee on Developmental Toxicology. Scientific frontiers in developmental toxicology and risk assessment. National Academies Press; 2000.
  • 30. Armatas V. Mental retardation: Definitions, etiology, epidemiology and diagnosis. J Sport Health Res. 2009;1(2):112-22.
  • 31. Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: A review and integration of findings. Arch Pediatr Adolesc Med. 2007;161(4):326-33. doi: 10.1001/archpedi.161.4.326. [PubMed: 17404128].
  • 32. Schroeder SR. Mental retardation and developmental disabilities influenced by environmental neurotoxic insults. Environ Health Perspect. 2000;108 Suppl 3:395-9. doi: 10.1289/ehp.00108s3395. [PubMed: 10852834]. [PubMed Central: PMC1637836].
  • 33. Bennett JE, Dolin R, Blaser MJ. Mandell, douglas, and bennett's principles and practice of infectious diseases: 2-volume set. Elsevier Health Sciences; 2014.
  • 34. McIntyre J, Newell ML. Congenital and perinatal infections prevention, diagnosis and treatment. Illustrated ed. Cambridge University Press; 2000. doi: 10.1136/sti.77.1.79-c.
  • 35. Shevell M. Global developmental delay and mental retardation or intellectual disability: Conceptualization, evaluation, and etiology. Pediatr Clin North Am. 2008;55(5):1071-84. xi. doi: 10.1016/j.pcl.2008.07.010. [PubMed: 18929052].
  • 36. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, et al. Evaluation of mental retardation: Recommendations of a consensus conference: American College of Medical Genetics. Am J Med Genet. 1997;72(4):468-77. [PubMed: 9375733].
  • 37. Moeschler JB, Shevell M, American Academy of Pediatrics Committee on G. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics. 2006;117(6):2304-16. doi: 10.1542/peds.2006-1006. [PubMed: 16740881].
  • 38. Filipek PA, Accardo PJ, Ashwal S, Baranek GT, Cook EJ, Dawson G, et al. Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55(4):468-79. [PubMed: 10953176].
  • 39. Randall M, Egberts KJ, Samtani A, Scholten RJ, Hooft L, Livingstone N, et al. Diagnostic tests for autism spectrum disorder (ASD) in preschool children. Cochrane Database Syst Rev. 2018;7. CD009044. doi: 10.1002/14651858.CD009044.pub2. [PubMed: 30075057].
  • 40. Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay: Report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77(17):1629-35. doi: 10.1212/WNL.0b013e3182345896. [PubMed: 21956720].
  • 41. Dobyns WB, Stratton RF, Parke JT, Greenberg F, Nussbaum RL, Ledbetter DH. Miller-Dieker syndrome: Lissencephaly andmonosomy 17p. J Pediatr. 1983;102(4):552-8. doi: 10.1016/s0022-3476(83)80183-8.
  • 42. Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, Ballif BC, et al. Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr. 2006;149(1):98-102. doi: 10.1016/j.jpeds.2006.02.006. [PubMed: 16860135].
  • 43. Ballif BC, Rorem EA, Sundin K, Lincicum M, Gaskin S, Coppinger J, et al. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A. 2006;140(24):2757-67. doi: 10.1002/ajmg.a.31539. [PubMed: 17103431].
  • 44. Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, et al. Clinical implementation of chromosomal microarray analysis: Summary of 2513 postnatal cases. PLoS One. 2007;2(3). e327. doi: 10.1371/journal.pone.0000327. [PubMed: 17389918]. [PubMed Central: PMC1828620].
  • 45. Sherr EH, Michelson DJ, Shevell MI, Moeschler JB, Gropman AL, Ashwal S. Neurodevelopmental disorders and genetic testing: Current approaches and future advances. Ann Neurol. 2013;74(2):164-70. doi: 10.1002/ana.23950. [PubMed: 23775934].
  • 46. Cooley LD, Lebo M, Li MM, Slovak ML, Wolff DJ, Working Group of the American College of Medical G, et al. American College of Medical Genetics and Genomics technical standards and guidelines: Microarray analysis for chromosome abnormalities in neoplastic disorders. Genet Med. 2013;15(6):484-94. doi: 10.1038/gim.2013.49. [PubMed: 23619274].
  • 47. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet. 2011;45:81-104. doi: 10.1146/annurev-genet-110410-132512. [PubMed: 21910631].
  • 48. Najmabadi H, Motazacker MM, Garshasbi M, Kahrizi K, Tzschach A, Chen W, et al. Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum Genet. 2007;121(1):43-8. doi: 10.1007/s00439-006-0292-0. [PubMed: 17120046].
  • 49. Kuss AW, Garshasbi M, Kahrizi K, Tzschach A, Behjati F, Darvish H, et al. Autosomal recessive mental retardation: Homozygosity mapping identifies 27 single linkage intervals, at least 14 novel loci and several mutation hotspots. Hum Genet. 2011;129(2):141-8. doi: 10.1007/s00439-010-0907-3. [PubMed: 21063731].
  • 50. Flore LA, Milunsky JM. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability. Semin Pediatr Neurol. 2012;19(4):173-80. doi: 10.1016/j.spen.2012.09.004. [PubMed: 23245550].
  • 51. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet. 2006;14(6):701-13. doi: 10.1038/sj.ejhg.5201595. [PubMed: 16721406].
  • 52. Humeau Y, Gambino F, Chelly J, Vitale N. X-linked mental retardation: Focus on synaptic function and plasticity. J Neurochem. 2009;109(1):1-14. doi: 10.1111/j.1471-4159.2009.05881.x. [PubMed: 19183273].
  • 53. Corbett MA, Bahlo M, Jolly L, Afawi Z, Gardner AE, Oliver KL, et al. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am J Hum Genet. 2010;87(3):371-5. doi: 10.1016/j.ajhg.2010.08.001. [PubMed: 20797691]. [PubMed Central: PMC2933342].
  • 54. Falace A, Filipello F, La Padula V, Vanni N, Madia F, De Pietri Tonelli D, et al. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet. 2010;87(3):365-70. doi: 10.1016/j.ajhg.2010.07.020. [PubMed: 20727515]. [PubMed Central: PMC2933335].
  • 55. Hamdan FF, Gauthier J, Spiegelman D, Noreau A, Yang Y, Pellerin S, et al. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med. 2009;360(6):599-605. doi: 10.1056/NEJMoa0805392. [PubMed: 19196676]. [PubMed Central: PMC2925262].
  • 56. Sheng M, Sala C. PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci. 2001;24:1-29. doi: 10.1146/annurev.neuro.24.1.1. [PubMed: 11283303].
  • 57. Carlisle HJ, Manzerra P, Marcora E, Kennedy MB. SynGAP regulates steady-state and activity-dependent phosphorylation of cofilin. J Neurosci. 2008;28(50):13673-83. doi: 10.1523/JNEUROSCI.4695-08.2008. [PubMed: 19074040]. [PubMed Central: PMC2615239].
  • 58. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, et al. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature. 1996;384(6609):567-70. doi: 10.1038/384567a0. [PubMed: 8955270].
  • 59. Carrie A, Jun L, Bienvenu T, Vinet MC, McDonell N, Couvert P, et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet. 1999;23(1):25-31. doi: 10.1038/12623. [PubMed: 10471494].
  • 60. Gambino F, Pavlowsky A, Begle A, Dupont JL, Bahi N, Courjaret R, et al. IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation. Proc Natl Acad Sci U S A. 2007;104(21):9063-8. doi: 10.1073/pnas.0701133104. [PubMed: 17502602]. [PubMed Central: PMC1885628].
  • 61. Matozaki T, Nakanishi H, Takai Y. Small G-protein networks: Their crosstalk and signal cascades. Cell Signal. 2000;12(8):515-24. [PubMed: 11027944].
  • 62. Bergmann C, Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Hausler M, et al. Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. Brain. 2003;126(Pt 7):1537-44. doi: 10.1093/brain/awg173. [PubMed: 12805098].
  • 63. Govek EE, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. Genes Dev. 2005;19(1):1-49. doi: 10.1101/gad.1256405. [PubMed: 15630019].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments